Criteria | DUR hospital | Number of prescriptions | Day 1 of treatment | Day 4 of treatment | ||
---|---|---|---|---|---|---|
(95% Confidence Interval) | ||||||
Indication for use | concurrent† | 771 | 82.27 | (78.48 – 85.70) | 84.51 | (81.29 – 87.73) |
retrospective‡ | 692 | 65.54 | (61.62 – 69.46) | 76.04 | (72.65 – 79.43) | |
control§ | 1 040 | 76.77 | (73.53 – 80.01) | 83.20 | (80.58 – 85.82) | |
Combination therapy | concurrent† | 771 | 45.20 | (40.95 – 49.45) | 55.26 | (51.52 – 59.00) |
retrospective‡ | 692 | 39.27 | (35.64 – 42.90) | 53.68 | (49.54 – 57.82) | |
control§ | 1 040 | 37.87 | (33.86 – 41.88) | 52.75 | (49.40 – 56.10) | |
Dosage (not further analysed) | concurrent† | 771 | 95.81 | (94.53 – 97.09) | 96.35 | (95.16 – 97.54) |
retrospective‡ | 692 | 96.33 | (94.94 – 97.72) | 98.16 | (97.03 – 99.29) | |
control§ | 1 040 | 96.72 | (95.59 – 97.85) | 97.24 | (96.20 – 98.28) | |
Drug Interactions (not further analysed) | concurrent† | 771 | 98.00 | (96.99 – 99.01) | 98.41 | (97.45 – 99.37) |
retrospective‡ | 692 | 96.97 | (95.75 – 98.19) | 96.88 | (95.67 – 98.09) | |
control§ | 1 040 | 97.34 | (96.43 – 98.25) | 98.37 | (97,59 – 99.15) |